Taste Disorders Clinical Trial
Official title:
Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers
NCT number | NCT05227157 |
Other study ID # | 00004 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 15, 2021 |
Est. completion date | May 1, 2022 |
Verified date | June 2022 |
Source | Centre Hospitalier de Valence |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a mono center , observational study carried out within otorhinolaryngology department in CH Valence. This is a descriptive and exploratory study in healthy volunteers. Based on the hypothesis that Metallic taste is imperfectly assessed, this study will provide a better understanding of the Metallic Taste.
Status | Completed |
Enrollment | 60 |
Est. completion date | May 1, 2022 |
Est. primary completion date | April 8, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years old - Healthy volunteers - Read, write and understand the French language - Patient affiliated to a social security system - Written and signed informed consent Exclusion Criteria: - head and Neck cancer history - olfactory and gustatory disorder - Refusal to participate in research - Patient under guardianship, deprived of liberty, safeguard of justice |
Country | Name | City | State |
---|---|---|---|
France | Ch Valence | Valence | Drome |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier de Valence |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | evaluation of the intensity of metallic taste | visual analogue scale (0 to 5); A score of 5 means the highest intensity of metallic taste | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04532632 -
Taste and Smell Impairment in Critically Ill COVID-19 Patients
|
||
Completed |
NCT04145453 -
Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults
|
N/A | |
Recruiting |
NCT02931812 -
Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation
|
||
Not yet recruiting |
NCT04661800 -
Study of Olfactory Disorders in Patients With Cardiac Amyloidosis
|
N/A | |
Completed |
NCT04302792 -
New Food Solutions for Cancer Patients
|
N/A | |
Withdrawn |
NCT05760079 -
Lactoferrin for COVID-19-Induced Taste or Smell Abnormality
|
N/A | |
Completed |
NCT03196440 -
Sensitivity of Basic Taste in Elderly
|
||
Completed |
NCT04235153 -
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
|
||
Recruiting |
NCT02304913 -
Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy
|
N/A | |
Recruiting |
NCT04881513 -
The Change of the Structure and Function of Taste Buds After the Otosclerosis Surgery
|
N/A | |
Completed |
NCT04543175 -
Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.
|
||
Completed |
NCT04923321 -
Taste Supra-thresholds Among a Sample of Depressed Egyptian Adult Under Anti-depressants Therapy
|
||
Completed |
NCT03599011 -
Gustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
|
||
Completed |
NCT04923425 -
Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
|
||
Completed |
NCT03498950 -
Changes in Sense of Taste of Patients Submitted to Hematopoietic Stem Cell Transplantation
|
N/A | |
Withdrawn |
NCT03043144 -
Taste And Smell TEsting in End Stage Renal Disease
|
N/A | |
Recruiting |
NCT06456008 -
Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat
|
||
Not yet recruiting |
NCT05104424 -
The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions
|
Phase 1 | |
Completed |
NCT01540045 -
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
|
||
Completed |
NCT00316563 -
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
|
Phase 2 |